Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine

Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine Publisher Pubmed

Mirzaei R^{1, 2} ; Mohammadzadeh R³ ; Mahdavi F⁴ ; Badrzadeh F⁵ ; Kazemi S⁶ ; Ebrahimi M⁷ ; Soltani F⁸ ; Kazemi S⁶ ; Jeda AS⁹ ; Darvishmotevalli M¹⁰ ; Yousefimashouf R¹ ; Keyvani H⁹ ; Karampoor S⁹

Source: International Immunopharmacology Published:2020

Abstract

Coronavirus disease 2019 (COVID-19) is a pandemic infectious disease caused by the novel coronavirus called SARS-CoV-2. There is a gap in our understanding regarding the immunopathogenesis of COVID-19. However, many clinical trials are underway across the world for screening effective drugs against COVID-19. Nevertheless, currently, no proven effective therapies for this virus exists. The vaccines are deemed as a significant part of disease prevention for emerging viral diseases, since, in several cases, other therapeutic choices are limited or non‐existent, or that diseases result in such an accelerated clinical worsening that the efficacy of treatments is restricted. Therefore, effective vaccines against COVID-19 are urgently required to overcome the tremendous burden of mortality and morbidity correlated with SARS-CoV-2. In this review, we will describe the latest evidence regarding outstanding vaccine approaches and the challenges for vaccine production. © 2020 Elsevier B.V.

Related Docs

View other Related Docs

1. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)

2. A Review of Covid-19 Vaccines and Major Considerations for Diabetic Patients, Biotechnology and Applied Biochemistry (2022)

3. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (2)

Mohammad Sharifzadeh (1)

Style	Citing Format
MLA	Mirzaei R, et al.. "Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine." International Immunopharmacology, vol. 88, no. , 2020, pp. -.
APA	Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, Soltani F, Kazemi S, Jeda AS, Darvishmotevalli M, Yousefimashouf R, Keyvani H, Karampoor S (2020). Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine. International Immunopharmacology, 88(), -.
Chicago	Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, Soltani F, et al.. "Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine." International Immunopharmacology 88, no. (2020): -.
Harvard	Mirzaei R et al. (2020) 'Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine', International Immunopharmacology, 88(), pp. -.
Vancouver	Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, et al.. Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine. International Immunopharmacology. 2020;88():-.
BibTex	@article{ author = {Mirzaei R and Mohammadzadeh R and Mahdavi F and Badrzadeh F and Kazemi S and Ebrahimi M and Soltani F and Kazemi S and Jeda AS and Darvishmotevalli M and Yousefimashouf R and Keyvani H and Karampoor S}, title = {Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine}, journal = {International Immunopharmacology}, volume = {88}, number = {}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Mirzaei R AU - Mohammadzadeh R AU - Mahdavi F AU - Badrzadeh F AU - Kazemi S AU - Ebrahimi M AU - Soltani F AU - Kazemi S AU - Jeda AS AU - Darvishmotevalli M AU - Yousefimashouf R AU - Keyvani H AU - Karampoor S TI - Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine JO - International Immunopharmacology VL - 88 IS - SP - EP - PY - 2020 ER -

Style

Citing Format

MLA

Mirzaei R, et al.. "Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine." International Immunopharmacology, vol. 88, no. , 2020, pp. -.

APA

Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, Soltani F, Kazemi S, Jeda AS, Darvishmotevalli M, Yousefimashouf R, Keyvani H, Karampoor S (2020). Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine. International Immunopharmacology, 88(), -.

Chicago

Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, Soltani F, et al.. "Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine." International Immunopharmacology 88, no. (2020): -.

Harvard

Mirzaei R et al. (2020) 'Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine', International Immunopharmacology, 88(), pp. -.

Vancouver

Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, et al.. Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine. International Immunopharmacology. 2020;88():-.

BibTex

@article{ author = {Mirzaei R and Mohammadzadeh R and Mahdavi F and Badrzadeh F and Kazemi S and Ebrahimi M and Soltani F and Kazemi S and Jeda AS and Darvishmotevalli M and Yousefimashouf R and Keyvani H and Karampoor S}, title = {Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine}, journal = {International Immunopharmacology}, volume = {88}, number = {}, pages = {-}, year = {2020} }

RIS

TY - JOUR
AU - Mirzaei R
AU - Mohammadzadeh R
AU - Mahdavi F
AU - Badrzadeh F
AU - Kazemi S
AU - Ebrahimi M
AU - Soltani F
AU - Kazemi S
AU - Jeda AS
AU - Darvishmotevalli M
AU - Yousefimashouf R
AU - Keyvani H
AU - Karampoor S
TI - Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine
JO - International Immunopharmacology
VL - 88
IS -
SP -
EP -
PY - 2020
ER -

Science Communicator Platform

Authors

Abstract